
BSP Pharmaceuticals is a CDMO focused on development, clinical and commercial production dedicated entirely to anticancer products without potency limitations, with a facility designed to handle conventional small molecules and ADCs (from conjugation to fill-finish) as well as other innovative therapies. The company covers manufacturing scales from early development to commercial production using advanced, safe technologies, operating a high-containment facility with an occupational exposure limit below 10 nanograms per cubic meter, from its plant near Rome in Latina Scalo, Italy, with a commercial branch in Princeton, NJ, and six sterile manufacturing suites.

Chưa có bình luận nào.
Để lại đánh giá & nhận xét